Article Information
History
- January 5, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Amena Keshawarz, PhD, MPHa,b,
- Shih-Jen Hwang, PhDa,b,
- Gha Young Lee, BSa,b,
- Zhi Yu, MB, PhDc,d,e,
- Chen Yao, PhDa,b,
- Anna Köttgen, MD, MPHf,g and
- Daniel Levy, MDa,b,*
- aPopulation Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
- bFramingham Heart Study, Framingham, MA, USA
- cBroad Institute of Harvard and MIT, Cambridge, Massachusetts
- dDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
- eWelch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland
- fInstitute of Genetic Epidemiology, Faculty of Medicine and Medical Center - University of Freiburg, Freiburg, Germany
- gDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
- ↵*Corresponding author: Daniel Levy, MD, Framingham Heart Study, 73 Mt. Wayte Avenue, Framingham, MA 01702, Phone: (508) 872-6556, levyd{at}nih.gov
Posted January 05, 2022.
Cardiovascular disease protein biomarkers are associated with kidney function: the Framingham Heart Study
